About the Company
Alien vs Predator is a 1994 first-person shooter developed by Rebellion Developments and published by Atari Corporation for the Atari Jaguar. It was also distributed in Japan by Mumin Corporation, where it became a pack-in game for the console. It is the first entry in the Alien vs. Predator franchise developed by Rebellion. Taking place in a simulation depicting the fall of the Golgotha training base camp, the game offers three playable scenarios: Alien, Predator, or a human of the Colonial Marines. The player is presented with a series of interconnected sublevels and ships to progress through. Each character has different objectives, abilities, weapons, and disadvantages. Alien vs Predator originally began as a corridor-based shooter for Atari Lynx that was under development by Images Software, featuring references to Dark Horse Comics' Aliens vs. Predator comic book series, but was cancelled as Atari focused its resources on the Jaguar. Production was later restarted, initially intended to be a port of the beat 'em up game of the same name developed by Jorudan for SNES, but was retooled into a first-person shooter when Atari submitted the proposal to 20th Century Fox and Activision, commissioning Rebellion to work on the game. It was produced by James Hampton, being one of his first projects when starting work for Atari after departing Lucasfilm Games. Alien vs Predator garnered generally favorable reception from critics, earned several awards from gaming publications and sold 52,223 copies by 1995, becoming the system's killer app. Atari had opened discussions with Beyond Games about their interest in developing a sequel for the Atari Jaguar CD, but dropped out of these negotiations shortly before the Jaguar was officially discontinued. A Jaguar CD conversion was also in the planning phase but never moved forward, though ideas provided by Atari to 20th Century Fox for this unreleased version were later used in Aliens Versus Predator (1999). Retrospective commentary has been equally favorable and is cited as one of the best games for the platform.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $JAGX News
Jaguar Health, Inc. (NASDAQ:JAGX) Q4 2023 Earnings Call Transcript
April 1, 2024 Jaguar Health, Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter ...
Why Jaguar Health Stock Is Up Today
Jaguar Health, Inc. (NASDAQ:JAGX) shares are trading higher Tuesday after the company announced it has signed an exclusive ...
Jaguar Health Appoints Biopharmaceutical Industry…
Catherine Miller Collis was instrumental in bringing about Jaguar's recent in-license agreement for FDA-approved Gelclair®, a protective gel for management of oral mucositis, a common, painful, and ...
Jaguar Health, Inc.
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. It operates through the Human Health and Animal Health segments.
Jaguar Health gets grant for treating secretory diarrhea associated with microvillous inclusion disease
Discover how Jaguar Health Inc's patent for treating congenital diarrheal disorders with Croton lechleri's proanthocyanidin polymer offers a groundbreaking solution for improving patient health.
Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of Stockholders
Company not implementing a reverse split at this timeTop line results forthcoming for company's phase 3 OnTarget trial of crofelemer for ...
Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International
About the Jaguar Health Family of Companies Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company ...
Q4 2023 Jaguar Health Inc Earnings Call
Lisa Conte; President, Chief Executive Officer, Director; Jaguar Health Inc Carol Lizak; Chief Financial Officer; Jaguar Health Inc Massimo Mineo; President; Jaguar Health Inc Operator Before I ...
Jaguar Health Inc (JAGX)
Napo Pharmaceuticals (Napo), a Jaguar Health (JAGX) (Jaguar) family company, today announced that the Japan Patent Office has issued a new Japan patent to Napo for methods for... Jaguar Health's ...
Jaguar Health, Inc. (NASDAQ:JAGX) Q4 2023 Earnings Call Transcript
Jaguar Health, Inc. (NASDAQ:JAGX) Q4 2023 Earnings Call Transcript April 1, 2024 Jaguar Health, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter ...
Jaguar Health Inc JAGX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Jaguar Health, Inc. (NASDAQ:JAGX) Q4 2023 Earnings Call Transcript
Jaguar Health, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Before I turn the call over to management ...
Loading the latest forecasts...